<DOC>
	<DOC>NCT01774864</DOC>
	<brief_summary>Study Design : multi-center, double-blind, placebo-controlled, randomized, parallel group, fixed dose design Phase : Phase III</brief_summary>
	<brief_title>Efficacy and Safety Study of Udenafil to Treat Erectile Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Udenafil</mesh_term>
	<criteria>Male patients aged 20 years or more diagnosed with ED Had uncontrolled blood pressure Had hepatic or renal dysfunction Was currently under anticancer chemotherapy Had a treatments for ED using other PDE5 inhibitors</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>